Agilent Technologies (A) Stock News

Agilent Technologies (NYSE: A) announced that Senior Vice President and CFO Bob McMahon will step down effective July 31, as he relocates to the East Coast for family reasons. Rodney Gonsalves, the company's current corporate controller and principal accounting officer, will serve as interim CFO while a global search for McMahon's successor is conducted.

The company also confirmed that its Q3 FY2025 financial results, to be released on August 27, are expected to be within the previously provided guidance range. Agilent maintains confidence in its long-term plans.

Agilent Technologies announced plans to showcase new laboratory equipment at HPLC 2025 in Bruges, Belgium. The company will introduce their new Hybrid Multisampler and LC Single Quadrupole Mass Spectrometers. The InfinityLab Pro iQ Series features enhanced sensitivity for analyzing oligonucleotides, therapeutic peptides, and proteins, with real-time status feedback and mass-based fraction collection capabilities. The eco-friendly system has earned MyGreenLab ACT EcoLabel 2.0 certification. The 1290 Infinity III Hybrid Multisampler offers both traditional flow-through and Feed Injection Mode, reducing sample preparation time and ensuring better peak shapes. Early adopters like Novopor Advanced Science report significant workflow improvements, praising the system's robustness, reproducibility, and user-friendly interface. Agilent will also preview a new fluorescence detector and showcase enhanced serviceable flow cells and expanded Bio Core offerings.

Agilent Technologies (NYSE: A) reported strong Q2 FY2025 financial results with revenue of $1.67 billion, representing 6.0% reported growth and 5.3% core growth year-over-year. The company's GAAP net income was $215 million ($0.75 EPS), down 29% from Q2 2024, while non-GAAP net income reached $373 million ($1.31 EPS), up 7%. By segment, Life Sciences and Diagnostics Markets Group revenue grew 8% to $654 million, Agilent CrossLab Group increased 7% to $713 million, while Applied Markets Group declined 1% to $301 million. For FY2025, Agilent projects revenue between $6.73-6.81 billion (3.4-4.6% growth) and non-GAAP EPS of $5.54-5.61. Q3 outlook expects revenue of $1.645-1.675 billion with non-GAAP EPS of $1.35-1.37.

Agilent Technologies (NYSE: A) has appointed August Specht, Ph.D. as its new Chief Technology Officer, effective June 9, 2025. Specht joins Agilent from Thermo Fisher Scientific, where he served as vice president of Global R&D for the Chromatography and Mass Spectrometry Division. With over 25 years of experience in analytical instruments, software, and consumables development, Specht brings extensive expertise in R&D, product management, strategy, and business development from his roles at Thermo Fisher and Varian Instruments.

Specht holds a B.S. in Chemistry from Queen's University, a Ph.D. in Analytical Chemistry from the University of British Columbia, and an MBA from UC Berkeley. Agilent, a global leader in analytical and clinical laboratory technologies, reported revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide.

Agilent Technologies (NYSE: A) has announced significant enhancements to its 8850 Gas Chromatograph (GC), now featuring compatibility with single and triple quadrupole mass spectrometry (MS) systems. The upgraded system stands out as one of the fastest and smallest benchtop GC/MS available, delivering up to 300°C/min oven ramp rates and fast cool-down times.

Key improvements include increased temperature range, compatibility with CTC PAL3 Series 2 Autosampler Systems, Multi-Mode Inlet (MMI), and backflush capabilities. The system achieves 45% less power usage compared to other benchtop GC systems, supporting sustainability goals while maintaining high performance. When integrated with 5977C, 7000E, or 7010D MS systems, it provides enhanced molecular identification and quantification capabilities for chemicals, energy, food, environmental, and forensic laboratories.

Agilent Technologies has launched the InfinityLab Pro iQ Series, a next-generation liquid chromatography-mass detection system. The series includes two models: the InfinityLab Pro iQ and Pro iQ Plus, designed for analyzing therapeutic molecules, oligonucleotides, peptides, and proteins. The Pro iQ Plus features an expanded mass range of m/z 2-3,000 and enhanced sensitivity through Agilent Jet Stream technology, while the Pro iQ system offers a mass range of m/z 2-1,600 for small molecule analysis. These systems serve diverse markets including pharmaceutical, biopharmaceutical, academic research, environmental testing, and food safety sectors. The technology enables mass confirmation, impurity profiling, biomolecule characterization, trace contaminant detection, and compound purification with greater specificity than traditional UV detection.

Agilent Technologies (NYSE: A) has declared a quarterly dividend of 24.8 cents per share of common stock. The dividend will be paid on July 23, 2025, to shareholders of record as of July 1, 2025. The company notes that future dividend amounts and timing will be subject to board approval.

Agilent Technologies (NYSE: A) has announced two significant additions to its Board of Directors: Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, effective May 21, 2025. Soriot brings extensive pharmaceutical industry experience as AstraZeneca's CEO since 2012, while Gawlik Brown contributes substantial financial and strategic expertise from her roles at Perrigo Company and Amgen. The appointments coincide with Agilent's three-year Ignite Transformation initiative.

Simultaneously, Heidi Kunz is retiring from the Board after more than 20 years of service, having joined at the company's inception in 2000. Agilent, which generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide, continues its commitment to balanced Board refreshment.

Agilent Technologies (NYSE: A) has announced that its new Infinity III LC Series liquid chromatography instruments have received the My Green Lab ACT Ecolabel 2.0 certification, becoming the first Agilent instruments to achieve this distinction. The series features energy-efficient workflows, automated tasks, and optimized solvent management to support sustainable laboratory operations. Notable innovations include a modular design allowing Infinity II LC upgrades and the industry-first capability to provide CO2 footprint information to customers. The certification reflects Agilent's commitment to sustainable scientific innovation, helping laboratories reduce their ecological footprint while maintaining high-quality results. The My Green Lab ACT Ecolabel 2.0 represents an evolution in lab product sustainability assessment, using standardized, science-based methods to evaluate environmental impact.